Taiwan's National Health Insurance (NHI) system has approved its first-ever patient to receive a one-time NT$49 million (US$1.53 million) drug for spinal muscular atrophy (SMA), which was added to a list of covered treatments earlier this month, an official said Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
New labor minister visits branch where worker committed suicide
11/26/2024 11:08 PM - Politics
President Lai reiterates commitment to strengthen Taiwan's defense
11/26/2024 11:04 PM - Society
Group calls on MOL to axe employment stabilization fee
11/26/2024 10:45 PM - Society
Norwegian man indicted for marijuana possession during Taiwan transit
11/26/2024 10:25 PM - Politics
Key suspect's detention extended in Core Pacific City corruption probe
11/26/2024 08:48 PM